diagnost
test
play
vital
part
primari
healthcar
provid
valuabl
insight
support
decis
regard
treatment
referr
secondari
patient
outcom
greatli
improv
diagnost
test
use
exclud
diseas
identifi
patient
benefit
downstream
action
initi
modifi
stop
withhold
primari
care
diagnost
process
tradit
reli
laboratori
test
laboratori
inform
must
therefor
accur
reliabl
reproduc
although
diagnost
question
rapid
deliveri
test
result
import
tradit
centralis
laboratori
tend
highlight
qualiti
reliabl
test
mani
diseas
care
provid
patient
increasingli
expect
specialis
diagnost
test
perform
quickli
easili
provid
result
within
led
develop
analys
perform
point
care
commonli
known
poc
test
reason
implement
poct
vari
accord
set
emerg
depart
intens
care
unit
poct
use
find
test
result
immedi
help
guid
decis
set
access
healthcar
facil
typic
limit
set
poct
benefici
term
eas
use
independ
physic
presenc
primari
care
set
poct
typic
use
prevent
unnecessari
referr
specialis
secondari
care
guid
diagnost
treatment
decis
provid
reassur
patient
exampl
exclud
ill
rapid
analysi
also
lead
improv
clinic
perform
sinc
elimin
potenti
long
interv
patient
initi
examin
discuss
test
first
major
systemat
review
poct
primari
care
publish
year
ago
hobb
et
conclud
evid
support
gener
introduct
poct
gener
practic
low
sinc
poc
diagnost
market
grown
substanti
continu
increas
develop
new
support
technolog
novel
biomark
wireless
connect
nanoparticl
techniqu
inform
share
expect
global
poc
diagnost
market
reach
billion
despit
grow
market
primari
care
clinician
gener
hesit
implement
poct
practic
accord
studi
poc
blood
test
jone
et
mainli
concern
accuraci
test
limit
use
recent
survey
gener
practition
gp
identifi
sever
theme
regard
gp
perceiv
facilit
barrier
implement
poct
theme
workload
clinic
util
patient
satisfact
reimburs
legisl
technic
perform
connect
train
mainten
similar
survey
studi
netherland
found
compar
result
dutch
gp
believ
proven
effect
clinic
manag
test
reliabl
among
import
aspect
studi
aim
systemat
review
recent
literatur
pertain
evalu
usag
poct
primari
care
investig
whether
outcom
evid
report
literatur
reflect
previous
establish
import
gp
decis
implement
poct
prisma
guidelin
follow
carri
systemat
review
avail
poct
primari
care
sinc
review
aim
identifi
poct
implement
primari
care
type
primari
research
studi
includ
initi
search
reason
requir
specif
outcom
measur
report
initi
search
specif
studi
characterist
use
part
inclus
criteria
review
protocol
systemat
review
provid
appendix
seri
step
follow
two
databas
scopu
medlin
search
relev
english
dutch
public
initi
search
perform
septemb
search
includ
term
text
word
relat
intervent
poc
diagnost
set
primari
care
search
queri
use
scopu
format
poct
point
care
point
care
test
rapid
test
bedsid
test
near
patient
test
diagno
primari
care
gener
pract
gp
primari
healthcar
primari
health
care
public
met
follow
inclus
criteria
select
review
public
focu
poc
diagnost
technolog
public
report
exampl
scorecard
methodolog
diagnos
patient
point
care
decis
support
tool
onlin
cloud
system
result
share
electron
health
record
etc
excludedpubl
focu
specif
poc
diagnost
technolog
provid
gener
summari
poctspubl
focu
primari
care
public
focus
secondari
care
excludedpubl
focu
countri
public
explicitli
state
focu
remot
rural
area
exclud
even
within
develop
countrypubl
appli
studi
evalu
poct
term
effect
perform
usag
applic
includ
qualit
studi
survey
interview
model
studi
review
exclud
remov
duplic
public
initi
search
result
abstract
screen
determin
whether
public
met
inclus
criteria
public
undoubtedli
fail
meet
inclus
criteria
base
abstract
screen
exclud
assess
doubt
whether
public
met
inclus
criteria
includ
assess
abstract
screen
perform
one
review
dl
potenti
issu
discuss
second
review
hk
requir
assess
includ
public
perform
one
review
dl
data
extract
manual
one
review
dl
studi
microsoft
excel
version
predefin
label
column
follow
inform
extract
includ
public
studi
design
classifi
accord
one
three
categori
name
empir
studi
trial
cohort
studi
etc
qualit
studi
interview
survey
etc
model
studyif
relev
countri
studi
perform
studi
individu
countri
count
separatelyif
applic
role
manufactur
play
studi
classifi
one
seven
categori
name
manufactur
provid
financi
support
studi
b
manufactur
fund
studi
c
manufactur
provid
analysertest
manufactur
fund
studi
provid
analysertest
e
one
author
employ
manufactur
f
manufactur
play
part
studi
g
noth
specifi
fund
manufactur
involvementth
name
poc
devicetest
evaluatedth
biomarkerassay
measur
poct
studi
evalu
one
poct
separ
data
entri
row
ad
individu
test
evalu
assess
test
evalu
studi
assess
summaris
extent
predefin
determin
report
determin
identifi
key
factor
affect
decis
implement
poct
primari
care
determin
list
tabl
determin
applic
poct
specif
rather
diseas
preval
gp
practic
frequenc
use
room
innov
risk
exampl
frequenc
use
room
innov
determin
associ
directli
gp
practic
impact
risk
test
would
differ
diseas
expect
determin
report
evalu
frequent
other
uncertainti
first
review
dl
whether
public
discuss
certain
determin
examin
second
review
hk
occas
two
review
could
agre
decis
third
review
involv
make
final
decis
either
rk
mjij
data
extract
includ
public
summaris
text
tabl
format
provid
descript
synthesi
find
result
divid
accord
biomarkerassay
test
measur
total
studi
obtain
initi
search
medlin
scopu
databas
ensur
search
result
comprehens
set
relev
public
select
search
queri
broad
howev
result
larg
number
public
exclud
abstract
screen
mostli
public
focus
someth
specif
poc
diagnost
screen
abstract
studi
includ
assess
assess
studi
includ
final
review
studi
mostli
exclud
base
assess
focu
poc
diagnost
n
instead
describ
tool
strategi
guidelin
support
poc
test
prisma
flow
diagram
search
present
appendix
includ
studi
consist
appli
studi
qualit
studi
simul
studi
studi
use
appli
qualit
method
major
studi
appli
netherland
n
us
n
uk
n
follow
spain
n
finland
n
australia
n
canada
n
studi
manufactur
test
evalu
provid
support
either
fund
studi
full
n
partial
n
provid
analys
test
n
fund
studi
provid
analys
test
n
singl
studi
one
author
employe
manufactur
major
studi
n
manufactur
involv
wherea
studi
noth
specifi
fund
manufactur
involv
studi
synthesi
set
test
evalu
identifi
percentag
determin
report
test
evalu
provid
figur
togeth
overal
weight
determin
found
four
determin
report
n
technic
perform
n
posit
predict
valu
n
neg
predict
valu
n
determin
report
least
evalu
room
innov
n
risk
n
follow
reimburs
n
legisl
n
scientif
evid
n
haemoglobin
test
measur
glycat
haemoglobin
give
indic
averag
blood
glucos
level
past
day
see
preval
diabet
continu
rise
year
time
manag
particularli
import
primari
care
pathway
patient
diabet
remain
appendix
b
tabl
list
poct
identifi
review
provid
particular
order
three
evalu
test
dca
vantag
analyz
n
aler
afininion
analyz
n
system
n
protein
crp
acut
phase
protein
produc
liver
inflamm
occur
measur
crp
level
help
identifi
patient
high
risk
respiratori
tract
infect
inflammatori
diseas
cardiovascular
diseas
support
earli
detect
seriou
infect
diseas
crp
test
increasingli
introduc
primari
list
crp
poct
identifi
review
provid
appendix
b
tabl
reader
ii
n
aler
afininion
analyz
n
manufactur
aler
evalu
literatur
protein
fragment
produc
blood
clot
dissolv
bodi
high
level
therefor
typic
use
assess
risk
thrombot
episod
exclud
condit
deep
vein
thrombosi
pulmonari
appendix
b
tabl
list
poct
identifi
review
provid
respiratori
syncyti
viru
rsv
common
viru
caus
lower
respiratori
tract
infect
especi
infant
toddler
sinc
reinfect
occur
throughout
life
specif
fall
winter
gp
emerg
depart
typic
met
surg
patient
visit
colder
influenza
commonli
known
flu
also
particularli
preval
children
winter
month
caus
similar
season
overflow
patient
influenza
infecti
diseas
caus
febril
respiratori
ill
typic
remain
undiagnos
sinc
symptom
overlap
significantli
viral
bacteri
poc
devic
rsv
influenza
major
posit
impact
patient
care
reduc
unnecessari
diagnost
test
antibiot
list
poct
influenza
rsv
identifi
review
provid
appendix
b
tabl
addit
poct
also
test
measur
calprotectin
streptococcu
pyogen
bnp
bladder
carcinoma
uric
acid
inr
iga
defici
chlamydia
among
other
major
test
one
evalu
list
test
evalu
provid
appendix
b
tabl
clear
inconsist
report
identifi
evalu
gp
consid
import
certain
determin
publish
list
use
review
relev
poct
rather
diseas
preval
gp
practic
frequenc
use
room
innov
risk
determin
expect
underreport
none
evalu
address
aspect
relat
room
innov
wherea
one
evalu
assess
risk
aspect
test
frequenc
use
address
five
test
evalu
reimburs
n
legisl
n
also
rare
report
evalu
could
sinc
impact
determin
vari
countri
therefor
purpos
exclud
evalu
relev
inconsist
clinic
util
although
gp
perceiv
clinic
util
import
aspect
come
poct
rare
explicitli
includ
test
evalu
found
review
evalu
incorpor
aspect
clinic
util
analysi
andor
discuss
although
definit
clinic
util
use
paper
broad
ensur
encompass
aspect
clinic
util
could
certain
aspect
describ
test
evalu
account
one
reason
clinic
util
test
rare
mention
could
fact
clinic
util
often
impli
rather
describ
exampl
point
current
test
decis
make
without
explicitli
indic
poct
would
improv
furthermor
test
report
half
evalu
even
though
among
ten
import
determin
accord
gp
could
possibl
gp
expect
user
friendli
short
evid
properti
poct
properti
consid
high
prioriti
evalu
poct
technic
perform
consid
second
import
determin
among
gp
address
almost
half
evalu
studi
huddi
et
clinician
state
interview
poc
devic
abil
perform
multipl
test
combin
lipid
seen
addit
incent
purchas
could
explain
high
number
evalu
found
review
reader
ii
seven
evalu
crp
two
one
aler
afininion
analyz
six
evalu
crp
six
howev
devic
high
amount
evalu
exampl
flex
immunoassay
analys
perform
six
test
procalcitonin
crp
troponin
troponin
yet
one
evalu
case
test
identifi
review
howev
sinc
instrument
requir
larg
volum
blood
therefor
venipunctur
instead
fingerpick
may
consid
therefor
studi
investig
devic
similar
devic
without
use
poct
terminolog
may
miss
care
taken
interpret
absolut
number
evalu
per
test
test
may
avail
market
longer
other
could
therefor
evalu
year
respect
aforement
test
earliest
year
inform
regard
flex
found
one
test
evalu
review
reader
ii
earliest
inform
test
test
evalu
review
n
n
n
n
n
poct
mani
evalu
review
exampl
inr
test
although
poc
inr
test
use
outpati
lab
anticoagul
clinic
refer
standard
remain
clinic
laboratori
use
poc
inr
test
becom
popular
test
patient
easili
use
devic
monitor
inr
report
result
clinician
either
person
via
telephon
would
adjust
anticoagul
dose
necessari
anoth
use
patient
patient
test
inr
dose
use
predetermin
algorithm
poct
may
also
appli
patient
focu
review
relat
applic
test
gener
practic
evalu
includ
worth
mention
larg
number
n
identifi
test
manufactur
four
compani
name
aler
n
roch
n
quidel
n
pt
diagnost
n
wherea
remaind
test
n
manufactur
total
differ
compani
poct
manufactur
four
compani
also
test
evalu
total
almost
half
n
evalu
review
test
manufactur
evalu
test
manufactur
aler
roch
quidel
pt
diagnost
respect
although
test
evalu
studi
case
perform
collect
addit
evid
test
perform
ad
valu
may
also
serv
purpos
increas
awar
test
avail
amongst
care
profession
biggest
limit
review
miss
studi
report
name
manufactur
poct
evalu
furthermor
devic
discontinu
renam
provid
reduc
evid
base
factor
could
caus
bia
conclus
addit
bia
could
also
caus
limit
test
select
appli
studi
primari
care
possibl
exclud
evalu
devic
secondari
care
test
applic
primari
well
miss
howev
poct
truli
relev
primari
care
expect
least
one
studi
evalu
primari
care
set
would
found
identifi
test
presum
avail
market
longer
period
time
other
make
absolut
number
evalu
per
test
hard
interpret
determin
investig
review
identifi
base
review
exist
literatur
rel
import
determin
howev
could
specif
dutch
gp
two
specif
poct
use
refer
assign
weight
therefor
uncertain
whether
determin
rel
import
transfer
poct
set
review
show
despit
grow
market
rapid
develop
new
poct
studi
evalu
test
fail
report
key
factor
adopt
import
innov
diagnost
primari
care
ensur
evalu
test
use
primari
care
clinician
futur
evalu
focu
technic
perform
aspect
test
also
report
aspect
relat
clinic
util
risk
none
author
contribut
design
studi
dl
hk
develop
search
strategi
dl
perform
data
extract
synthesi
author
contribut
select
procedur
data
interpret
data
analysi
result
interpret
discuss
draft
manuscript
approv
final
version
manuscript
submiss
